What happened
SK Bioscience disclosed a supply contract, worth US$15.6M, about 3.67% of its recent annual revenue, running through Jun 2027.
For context, this single contract equals about 3.67% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$15.6M |
| vs. recent revenue | 3.67% |
| Through | Jun 2027 (from Jun 2026) |
| Filed | 2026-06-23, Supply contract signed |
| Source | DART rcept 20260623800501 → open original filing |
Source: DART. Information only, not investment advice.